Harpoon Therapeutics Banks $70M Series C Financing

Harpoon Therapeutics, Inc. announced on 11/11/18 the closing of a $70 million Series C equity financing. OrbiMed served as the lead new investor, along with new investors Cormorant, Ridgeback Capital Investments, Lilly Asia Ventures (LAV) and NS Investment.